Table 3.
Multivariable analysis of survival outcomes.
| Parameters | Overall survival | Disease-free survival | Breast cancer specific survival | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| AR expression | ||||||
| Negative | 1 | 1 | 1 | |||
| Positive | 0.66 (0.35, 1.28) | 0.2 | 1 (0.57, 1.73) | > 0.9 | 0.97 (0.46-2.07) | > 0.9 |
| Tumor Size | ||||||
| T1 | 1 | 1 | 1 | |||
| T2 | 2.06 (0.47,8.99) | 0.3 | 3.39 (0.79, 14.46) | 0.1 | 2.66 (0.34-20.66) | 0.4 |
| T3&T4 | 4.18 (0.94, 18.51) | 0.06 | 6.23 (1.4, 27.66) | 0.02 | 5.11 (0.65-40.1) | 0.12 |
| Lymph node status | ||||||
| N0 | 1 | 1 | 1 | |||
| N1 | 2.40 (1.14, 5.03) | 0.02 | 2.06 (1.08, 3.9) | 0.03 | 3.14 (1.2-8.12) | 0.02 |
| N2&N3 | 3.23 (1.31, 7.96) | 0.01 | 2.64 (1.13, 6.17) | 0.03 | 3.01 (0.9-10.07) | 0.07 |
| Neoadjuvant CTx | ||||||
| No | 1 | 1 | 1 | |||
| Yes | 1.1 (0.53, 2.27) | 0.8 | 0.86 (0.46, 1.6) | 0.64 | 1.45 (0.56-3.76) | 0.5 |
| Surgery type | ||||||
| BCS | 1 | 1 | 1 | |||
| Mastectomy ± Reconstruction | 2.47 (1.17, 5.22) | 0.017 | 1.71 (0.89, 3.28) | 0.11 | 3.14 (1.14-8.62) | 0.03 |
HR, Hazard ratio; CI, Confidence interval.